stockportfolio.pro
BAM vs CME: Which Stock Is the Better Buy?
Brookfield Asset Management Ltd. and CME Group Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Financial Services.
AI verdict — BAM vs CME, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Brookfield Asset Management Ltd. (BAM) | CME Group Inc. (CME) | |
|---|---|---|
| Market cap | $72.8B | $85.5B |
| Revenue (latest FY) | $4.61B | $6.52B |
| Net income (latest FY) | $2.48B | $4.02B |
| Revenue growth (5y CAGR) | 7.0% | 6.0% |
| Net margin | 53.9% | 61.7% |
| Return on equity | 30.6% | 14.0% |
| P/E ratio | 29.2 | 20.2 |
| Dividend yield | 4.4% | 2.2% |
| Profitable years (of last 10) | 4 | 10 |
| Positive free cash flow | — | Yes |
See the full BAM vs CME breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open BAM's full financials → Open CME's full financials →Frequently asked questions
Which is bigger, BAM or CME?
CME Group Inc. is larger by market capitalization — $85.5B versus $72.8B.
Which grows faster, BAM or CME?
Over the last five fiscal years, Brookfield Asset Management Ltd. grew revenue faster — 7.0%/yr versus 6.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.